Details for Patent: 8,765,732
✉ Email this page to a colleague
Which drugs does patent 8,765,732 protect, and when does it expire?
Patent 8,765,732 protects TAZVERIK and is included in one NDA.
This patent has ninety-six patent family members in thirty-six countries.
Summary for Patent: 8,765,732
| Title: | Aryl- or heteroaryl-substituted benzene compounds |
| Abstract: | The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes. |
| Inventor(s): | Kuntz; Kevin Wayne (Woburn, MA), Chesworth; Richard (Concord, MA), Duncan; Kenneth William (Norwood, MA), Keilhack; Heike (Belmont, MA), Warholic; Natalie (Brighton, MA), Klaus; Christine (Weymouth, MA), Knutson; Sarah Kathleen (Cambridge, MA), Wigle; Timothy James Nelson (Waltham, MA), Seki; Masashi (Tsukuba, JP), Shirotori; Syuji (Tsukuba, JP), Kawano; Satoshi (Tsukuba, JP) |
| Assignee: | Epizyme, Inc. (Cambridge, MA) |
| Application Number: | 13/722,807 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 8,765,732
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA POSITIVE FOR AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) MUTATION | ⤷ Sign Up | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,765,732
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 086008 | ⤷ Sign Up | |||
| Australia | 2012242595 | ⤷ Sign Up | |||
| Brazil | 112013026324 | ⤷ Sign Up | |||
| Brazil | 122020006541 | ⤷ Sign Up | |||
| Canada | 2832843 | ⤷ Sign Up | |||
| Canada | 3086473 | ⤷ Sign Up | |||
| Chile | 2013002898 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
